Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era
Open Access
- 1 April 2016
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 100, 190-208
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- Pheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundCancer Genetics, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Germline mutations in BAP1 predispose to melanocytic tumorsNature Genetics, 2011
- Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypesEuropean Journal of Surgical Oncology, 2011
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Germline mutations in TMEM127 confer susceptibility to pheochromocytomaNature Genetics, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumorsMolecular and Cellular Endocrinology, 2009
- The impact of O2 availability on human cancerNature Reviews Cancer, 2008
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006